XOMAP — XOMA Royalty Corporation · P/E 25, rev $28.5M

XOMA Royalty Corporation (XOMAP) is a biotechnology company listed on NASDAQ.

Latest reported XOMAP revenue for 2024-12-31 was $28.5M. Net income was -$13.8M. Revenue was up 498.7% from 2023-12-31 to 2024-12-31. XOMAP currently screens at market cap $0 and trailing P/E 25.4.

Use this XOMAP page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the XOMAP quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the XOMAP SEC filings page. Lician reads the product cache first so this HTML stays unique to XOMA Royalty Corporation even when a live quote feed is slow.